Abstract. Congenital nephrogenic diabetes insipidus (Cndi) is a rare inherited disease, characterized by an inability of the kidney to concentrate urine in response to vasopressin. Three different inheritance patterns have been described, i.e., the X-linked recessive form associated with arginine vasopressin V2 receptor (AVPR2) gene mutations, the autosomal recessive and dominant forms of Cndi associated with mutations in the aquaporin-2 (AQP2) gene encoding the vasopressinregulated water channel of the renal collecting duct. our case is an 18-year-old male patient who complained of severe polyuria since his infancy. But his developmental and growth status were normal. He was diagnosed as Cndi by water deprivation test and genomic dna sequencing, which revealed high plasma aVP levels but persistently low urine osmolalities to 6 h-water deprivation and the novel missense mutation S216F in exon4 of the AQP2 gene. immunohistochemistry of renal biopsied tissue revealed that most of the aQP2 labeling was seen intracellularly in a dotted pattern in the collecting duct principal cells. Immunoblotting of urine samples revealed significantly decreased urinary excretion of AQP2 (~7% of normal control). Here, we report a new case of Cndi associated with the novel missense mutation of the AQP2 gene.
CongenitAl nephrogenic diabetes insipidus is a rare inherited disorder characterized by an inability to concentrate urine in response to the antidiuretic effect of vasopressin [1] . The disorder causes polyuria of more than 3 liters per day, nocturia, functional obstruction, hypernatermia and compensatory polydipsia. Patients with this disorder exhibit hypernatremic dehydration, failure to thrive, irritability, and fever during infancy. The disorder is known to be caused by the mutations of AVPR2 gene or AQP2 gene. The former is associated with X-linked recessive form and the latter is associated with autosomal recessive or dominant inheritance [2] [3] [4] . About 10 % of CNDI might be caused by AQP2 gene mutations, and most of them are autosomal recessive forms [1] . The gene for human aQP2 has been localized to chromosomal region 12q13 [3] . So far, various mutations in the AQP2 gene have been demonstrated in both the autosomal recessive and dominant forms of ndi, in which mutations are distributed throughout the gene without any mutation hot spot [5] [6] [7] [8] [9] [10] . Here, we report a Korean male patient with Cndi caused by the novel missense mutation S216F in exon4 of the AQP2 gene.
Case Report
an 18-year-old man presented with severe polyuria which had occurred since his infancy. His prenatal note collected for 24 hours revealed markedly decreased AQP2 expression (approximately 7 %), compared to the urine sample of normal control volunteer (Fig. 1) . Immunofluorescence and electron microscopy of renal biopsied tissue revealed a trace of the iga deposition in the glomerulus without mesangial hypercellularity (not shown). immunoperoxidase labeling of aQP2 showed that apical aQP2 labeling in the cortical and outer medullary collecting duct was very sparse and most of the aQP2 labeling was in the cytoplasm in a dotted or speckled pattern (Fig. 2) . in contrast, aQP2 labeling in the control kidney from a patient with iga nephropathy showed apical labeling in the collecting duct. with such findings, he was clinically diagnosed as Cndi, and the AQP2 gene analysis was and natal history was unremarkable. He had no family history of ndi, and his parents were not consanguineous. He had polyuria, nocturia, an eager for water intake, and recurrent episodes of fever since his infancy. unless he drank enough water, he got nervous and irritable. He took herbal medication several times but it was not effective. His height was 172 cm and body weight was 67 kg. His developmental status was normal mentally and physically. on admission, blood pressure was 123/69 mmHg and pulse rate was 76 beats/min. daily urine output was more than 10 liters and urine specific gravity was 1.005. Urine osmolality and plasma osmolality were 58 mosm/KgH 2 o and 299 mosm/KgH 2 o, respectively. Serum sodium concentration was 146 mM/L, potassium concentration was 3.8 mM/L. Blood urea nitrogen and creatinine levels were 6.4 mg/dL and 0.89 mg/dL, respectively. Plasma antidiuretic hormone level was 8.39 pg/ml (normal range: 0 -6.7 pg/dL). during 6-hour of water deprivation test, he lost 3.9 kg of body weight with a drop of 18 mmHg in mean arterial blood pressure, but urine osmolality was unchanged (between 58 and 66 mosm/kgH 2 o), indicating a failure to concentrate urine (Table 1) . importantly, despite parenteral administration of ddaVP (5 u), urine osmolality was unchanged, compatible with nephrogenic diabetes insipidus (Table 1 ). Brain magnetic resonance imaging showed no abnormality, and ultrasonographic examination of both kidneys revealed no evidence of obstructive nephropathy including hydronephrosis. with his long sustained history since infancy, we considered congenital nephrogenic diabetes insipidus as a tentative diagnosis. immunoblotting of his urine sample uVol, urine volume; BP, blood pressure; SBP, systolic blood pressure; dBP, diastolic blood pressure; Bwt, body weight; uosm, urine osmolality; Posm, plasma osmolality; na/K, serum sodium concentration/serum potassium concentration. (Fig. 3) . one heterogenous missense point,
216
Ser(TCC) to Phe(TTC) in exon performed. genomic dna was extracted from the nucleated cells in the peripheral blood using a commercial kit (Puregene dna isolation kit, gentra system, Minneapolis). oRF (open reading frame) in exon 1 and ORF in exon 2 -4 with unilateral flanking intron of the AQP2 gene was amplified separately from the genomic dna by polymerase chain reaction (PCR, Fig. 3 ), and the amplified exon1 and exon 2 -4 were inserted to the vector (pBlusescript ii SK) to be cloned edge. our patient had only a missense mutation in exon 4 of the aQP2 gene and was diagnosed at age 18, although his symptoms had began to develop since infancy. Ultrasonographic findings of his kidneys did not reveal evidence of obstructive nephropathy including hydronephrosis, suggesting that his clinical manifestation was not as severe as the usual features seen in autosomal recessive form of Cndi [19, 20] . aQP2 proteins are usually not detected in the urine of patients suffering from autosomal recessive Cndi as a result of AQP2 gene mutation [21] . in the urine of our patient, however, aQP2 proteins were weakly (~ 7% of normal control) detected by immunoblotting. Moreover, immunohistochemistry of aQP2 in the patient's kidney showed sparse but distinct apical aQP2 labeling in the cortical collecting duct, although most of the aQP2 labeling was observed intracellularly in a dotted or speckled pattern indicating a defect in the vasopressin action on AQP2 trafficking and retention of aQP2 in certain subcellular compartment. expression of the mutant S216P aQP2 protein in Xenopus oocytes revealed a nonfunctional water channel caused by an impaired routing to the plasma membrane [22] . Therefore, the mutant S216F aQP2 is inferred to have a severe impairment in trafficking to the apical membrane. Since patients with autosomal dominant mutations of AQP2 gene are likely to demonstrate more mild clinical manifestations than recessive form [5, 19, 20, 23] , the Cndi seen in this case is likely to be autosomal dominant form rather than recessive form. all mutations in dominant Cndi are found in the coding region of the C-terminal tail of aQP2, which plays an important role in aQP2 traf-4 of the AQP2 gene was detected in the patient (Fig. 4) . That is located on the transmembrane domain 6 of the aQP2. He was treated with hydrochlorothiazide and amiloride, but his polyuria was only partially relieved.
Discussion
aQP2 is the aVP-dependent water channel of the collecting duct [11] [12] [13] [14] . in the presence of aVP, solute-free water is reabsorbed osmotically through the principal cells of the collecting ducts, resulting in the excretion of concentrated urine. This antiuretic effect is mediated via a g protein-coupled V2 receptor that accumulates intracellular cyclic aMP and, increases protein kinase a activity. This lead to phosphorylation of aQP2, particularly on its Ser256 residue [15] [16] [17] , resulting in translocation of aQP2 water channels into the apical membrane [18] .
About 10% of patients diagnosed as CNDI have mutations in the AQP2 gene. deen et al. [3] found mutated and non-functional aQP2 in patients with severe nephrogenic diabetes insipidus (non-X-linked ndi). The patient appeared to carry two point mutations in the AQP2 gene, one resulting in substitution of a cysteine for arginine 187 (R187C) in the third extracellular loop of the aQP2 and the other resulting in substitution of a proline for serine 216 (S216P) in the sixth transmembrane domain [3] . The patient was diagnosed at 3 months after birth. in contrast, our patient had one heterogenous missense point, 216 Ser(TCC) to Phe(TTC) in exon 4 of the aQP2 gene, which has not been reported previously, to our knowl- ficking to the apical plasma membrane. Thus, AQP2 mutants in dominant ndi are sorted to other subcellular locations in the cells than wt-aQP2 [19, 20, 24, 25] . in contrast, this patient's missense mutation was in the transmembrane domain 6 of the aQP2, which aQP2 mutant needs to be examined in further study.
So far, renal histology in patients with Cndi has rarely been performed, since hydronephrosis is commonly accompanied, which limits the procedure of renal biopsy. Hironak, et al. [26] examined the kidney tissue of a 16-year-old male ndi patient which was normal except for a minor abnormality in the section of the tubule closest to the glomerulus. in this patient, except the changes of aQP2 labeling, thick fibrotic band-like structure around the cortical collecting ducts and scanty deposition of iga in the glomerulus were seen, but the specificity of both findings in CNDI could not be explored further. in addition, we could not perform his parents' AQP2 gene analysis due to their privacy issues, and thus the inheritance pattern
